Emflaza Approved for Duchenne Muscular Dystrophy 0 09.02.2017 22:15 «La Crosse Tribune» (lacrossetribune.com) THURSDAY, Feb. 9, 2017 (HealthDay News) --Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in people five years and older, the agency said Thursday in a news release. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
